...
首页> 外文期刊>Viruses >A Comprehensive Proteomics Analysis of the JC Virus (JCV) Large and Small Tumor Antigen Interacting Proteins: Large T Primarily Targets the Host Protein Complexes with V-ATPase and Ubiquitin Ligase Activities While Small t Mostly Associates with Those Having Phosphatase and Chromatin-Remodeling Functions
【24h】

A Comprehensive Proteomics Analysis of the JC Virus (JCV) Large and Small Tumor Antigen Interacting Proteins: Large T Primarily Targets the Host Protein Complexes with V-ATPase and Ubiquitin Ligase Activities While Small t Mostly Associates with Those Having Phosphatase and Chromatin-Remodeling Functions

机译:JC病毒(JCV)大小肿瘤抗原相互作用蛋白质的综合蛋白质组学分析:大T主要针对V-ATP酶和遍染素连接酶活性的宿主蛋白复合物,同时小T主要与具有磷酸酶和染色质重塑功能的蛋白质组成酶活性

获取原文
           

摘要

The oncogenic potential of both the polyomavirus large (LT-Ag) and small (Sm t-Ag) tumor antigens has been previously demonstrated in both tissue culture and animal models. Even the contribution of the MCPyV tumor antigens to the development of an aggressive human skin cancer, Merkel cell carcinoma, has been recently established. To date, the known primary targets of these tumor antigens include several tumor suppressors such as pRb, p53, and PP2A. However, a comprehensive list of the host proteins targeted by these proteins remains largely unknown. Here, we report the first interactome of JCV LT-Ag and Sm t-Ag by employing two independent “affinity purification/mass spectroscopy” (AP/MS) assays. The proteomics data identified novel targets for both tumor antigens while confirming some of the previously reported interactions. LT-Ag was found to primarily target the protein complexes with ATPase (v-ATPase and Smc5/6 complex), phosphatase (PP4 and PP1), and ligase (E3-ubiquitin) activities. In contrast, the major targets of Sm t-Ag were identified as Smarca1/6, AIFM1, SdhA/B, PP2A, and p53. The interactions between “LT-Ag and SdhB”, “Sm t-Ag and Smarca5”, and “Sm t-Ag and SDH” were further validated by biochemical assays. Interestingly, perturbations in some of the LT-Ag and Sm t-Ag targets identified in this study were previously shown to be associated with oncogenesis, suggesting new roles for both tumor antigens in novel oncogenic pathways. This comprehensive data establishes new foundations to further unravel the new roles for JCV tumor antigens in oncogenesis and the viral life cycle.
机译:先前已经在组织培养和动物模型中证明了多种状动脉大(LT-AG)和小(SM T-AG)肿瘤抗原的致癌电位。即使是麦PYV肿瘤抗原对发育侵袭性人体皮肤癌,Merkel细胞癌的贡献也已得到最近成立。迄今为止,这些肿瘤抗原的已知主要靶标包括几种肿瘤抑制剂,例如PRB,P53和PP2A。然而,这些蛋白质靶向的宿主蛋白质的综合列表仍然很大程度上是未知的。这里,通过使用两个独立的“亲和纯化/质谱”(AP / MS)测定,我们通过采用两个独立的“亲和纯化/质谱”(AP / MS)测定来报告JCV LT-AG和SM T-AG的第一种互组切蛋白。蛋白质组学数据鉴定了肿瘤抗原的新型靶,同时确认了一些先前报道的相互作用。发现LT-AG主要针对ATP酶(V-ATP酶和SMC5 / 6复合物),磷酸酶(PP4和PP1)和连接酶(E3-泛素)活性的蛋白质复合物。相反,SM T-AG的主要靶标被鉴定为SMARCA1 / 6,AIFM1,SDHA / B,PP2A和P53。通过生物化学测定进一步验证“LT-AG和SDHB”,“SM T-AG和SMARCA5”和“SM T-AG和SDH”之间的相互作用。有趣的是,本研究中鉴定的一些LT-AG和SM T-AG靶标的扰动均显示与肿瘤发生有关,表明新型致癌途径中肿瘤抗原的新作用。这种综合数据建立了新的基础,以进一步解开JCV肿瘤抗原在肿瘤发生和病毒生命周期中的新作用。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号